Sanofi Takes a $120M Hit as Potential Dengue Vaccine Blockbuster Dealt Safety Blow Post author:Sam Post published:November 29, 2017 Post category:BioPharma Sanofi’s setback could open the door for rival drugmaker Takeda. Source: BioSpace You Might Also Like Flushed With Cash, Shanghai Pharma Hunts for M&A in the U.S. and Europe January 23, 2018 Fully Loaded With Nearly 500 Employees in Rockville, GlaxoSmithKline Chief Lays Out 2018 Goals December 7, 2017 Merck & Co. CEO Resigns From American Manufacturing Council by Tweet August 13, 2017
Fully Loaded With Nearly 500 Employees in Rockville, GlaxoSmithKline Chief Lays Out 2018 Goals December 7, 2017
